Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab
LUCENT-1 (NCT03518086) Registered 04 May 2018 https://clinicaltrials.gov/study/NCT03518086 . LUCENT-2 (NCT03524092) Registered 10 May 2018 https://clinicaltrials.gov/study/NCT03524092 .
Authors
- Richard Moses (ORCID: https://orcid.org/0000-0002-1423-089X)
- Simin Baygani
- Bruce E. Sands (ORCID: https://orcid.org/0000-0001-5762-5042)
- Marla C. Dubinsky (ORCID: https://orcid.org/0000-0003-4968-5795)
- Toshifumi Hibi∥ (ORCID: https://orcid.org/0000-0002-6256-1204)
- Anthony Keohane
- David B. Clemow (ORCID: https://orcid.org/0000-0002-5328-8285)
- Simon P.L. Travis (ORCID: https://orcid.org/0000-0002-2690-4361)
- Alissa J. Walsh (ORCID: https://orcid.org/0000-0002-8994-1186)
- Stefan Schreiber
- Silvio Danese
- Theresa Hunter Gibble
Institutions
- Vita-Salute San Raffaele University (IT)
- Eli Lilly (United States) (US)
- University Hospital Schleswig-Holstein (DE)
- Oxford BioMedica (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
- Kitasato Institute Hospital (JP)
- Kitasato University (JP)
- Carrier (United States) (US)
- University of Lübeck (DE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s41687-025-00906-0
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Gilead Sciences
- Biogen
- Celgene
- Wellcome Trust
- Asahi Kasei Pharma Corporation
- Vertex Pharmaceuticals
- GW Pharmaceuticals
- EA Pharma Co., Ltd.
- Mylan
- Kissei
- Miyarisan Pharmaceutical
- European Crohn's and Colitis Organisation
- Celltrion
- Kyorin Pharmaceutical
- Glenmark Pharmaceuticals
- Novo Nordisk
- Astellas Pharma
- Otsuka Pharmaceutical
- Mitsubishi Tanabe Pharma Corporation
- Norman Collisson Foundation
- Sun Pharma
- Aspen
- Dr. Falk Pharma
- Genentech
- Allergan